Cargando…
Perioperative Outcomes in Patients Who Received Spinal Chloroprocaine for Total Hip or Knee Arthroplasty—Consecutive Case Series Study
Spinal anaesthesia is an established component of perioperative management for fast-track lower limbs arthroplasty. Short-acting local anaesthetics may present an interesting option for primary non-complicated knee (TKA) and hip (THA) arthroplasty. We describe the perioperative outcomes in patients...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572724/ https://www.ncbi.nlm.nih.gov/pubmed/36233638 http://dx.doi.org/10.3390/jcm11195771 |
_version_ | 1784810687591088128 |
---|---|
author | Alhefeiti, Khaleifah Patrascu, Ana-Maria Lustig, Sebastien Aubrun, Frederic Dziadzko, Mikhail |
author_facet | Alhefeiti, Khaleifah Patrascu, Ana-Maria Lustig, Sebastien Aubrun, Frederic Dziadzko, Mikhail |
author_sort | Alhefeiti, Khaleifah |
collection | PubMed |
description | Spinal anaesthesia is an established component of perioperative management for fast-track lower limbs arthroplasty. Short-acting local anaesthetics may present an interesting option for primary non-complicated knee (TKA) and hip (THA) arthroplasty. We describe the perioperative outcomes in patients operated under fixed 50 mg spinal chloroprocaine for total hip and knee replacement. In this retrospective case series study, 65 patients were analysed (median age 65 years, 55% females, benefit from THA (n = 31), TKA (n = 25), and unicompartmental knee arthroplasty (n = 9)). In all cases, anaesthesia duration (87 min) was sufficient for successful surgery (52 min). Up to 45% of patients (THA and less in TKA) developed postoperative pain in the post-anaesthesia care unit (PACU), requiring intravenous morphine titration (up to 7.5 mg). One patient developed severe breakthrough pain requiring advanced regional analgesia. The median PACU stay was up to 97 min (less in TKA), and the incidence of nausea and urinary retention was low. All patients were able to start physical therapy on the same day of surgery. These findings encourage the use of a short-acting agent for spinal anaesthesia in patients with primary non-complicated arthroplasty; however, the relay analgesia should be systematically implemented to avoid breakthrough pain in PACU. |
format | Online Article Text |
id | pubmed-9572724 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95727242022-10-17 Perioperative Outcomes in Patients Who Received Spinal Chloroprocaine for Total Hip or Knee Arthroplasty—Consecutive Case Series Study Alhefeiti, Khaleifah Patrascu, Ana-Maria Lustig, Sebastien Aubrun, Frederic Dziadzko, Mikhail J Clin Med Article Spinal anaesthesia is an established component of perioperative management for fast-track lower limbs arthroplasty. Short-acting local anaesthetics may present an interesting option for primary non-complicated knee (TKA) and hip (THA) arthroplasty. We describe the perioperative outcomes in patients operated under fixed 50 mg spinal chloroprocaine for total hip and knee replacement. In this retrospective case series study, 65 patients were analysed (median age 65 years, 55% females, benefit from THA (n = 31), TKA (n = 25), and unicompartmental knee arthroplasty (n = 9)). In all cases, anaesthesia duration (87 min) was sufficient for successful surgery (52 min). Up to 45% of patients (THA and less in TKA) developed postoperative pain in the post-anaesthesia care unit (PACU), requiring intravenous morphine titration (up to 7.5 mg). One patient developed severe breakthrough pain requiring advanced regional analgesia. The median PACU stay was up to 97 min (less in TKA), and the incidence of nausea and urinary retention was low. All patients were able to start physical therapy on the same day of surgery. These findings encourage the use of a short-acting agent for spinal anaesthesia in patients with primary non-complicated arthroplasty; however, the relay analgesia should be systematically implemented to avoid breakthrough pain in PACU. MDPI 2022-09-29 /pmc/articles/PMC9572724/ /pubmed/36233638 http://dx.doi.org/10.3390/jcm11195771 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Alhefeiti, Khaleifah Patrascu, Ana-Maria Lustig, Sebastien Aubrun, Frederic Dziadzko, Mikhail Perioperative Outcomes in Patients Who Received Spinal Chloroprocaine for Total Hip or Knee Arthroplasty—Consecutive Case Series Study |
title | Perioperative Outcomes in Patients Who Received Spinal Chloroprocaine for Total Hip or Knee Arthroplasty—Consecutive Case Series Study |
title_full | Perioperative Outcomes in Patients Who Received Spinal Chloroprocaine for Total Hip or Knee Arthroplasty—Consecutive Case Series Study |
title_fullStr | Perioperative Outcomes in Patients Who Received Spinal Chloroprocaine for Total Hip or Knee Arthroplasty—Consecutive Case Series Study |
title_full_unstemmed | Perioperative Outcomes in Patients Who Received Spinal Chloroprocaine for Total Hip or Knee Arthroplasty—Consecutive Case Series Study |
title_short | Perioperative Outcomes in Patients Who Received Spinal Chloroprocaine for Total Hip or Knee Arthroplasty—Consecutive Case Series Study |
title_sort | perioperative outcomes in patients who received spinal chloroprocaine for total hip or knee arthroplasty—consecutive case series study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572724/ https://www.ncbi.nlm.nih.gov/pubmed/36233638 http://dx.doi.org/10.3390/jcm11195771 |
work_keys_str_mv | AT alhefeitikhaleifah perioperativeoutcomesinpatientswhoreceivedspinalchloroprocainefortotalhiporkneearthroplastyconsecutivecaseseriesstudy AT patrascuanamaria perioperativeoutcomesinpatientswhoreceivedspinalchloroprocainefortotalhiporkneearthroplastyconsecutivecaseseriesstudy AT lustigsebastien perioperativeoutcomesinpatientswhoreceivedspinalchloroprocainefortotalhiporkneearthroplastyconsecutivecaseseriesstudy AT aubrunfrederic perioperativeoutcomesinpatientswhoreceivedspinalchloroprocainefortotalhiporkneearthroplastyconsecutivecaseseriesstudy AT dziadzkomikhail perioperativeoutcomesinpatientswhoreceivedspinalchloroprocainefortotalhiporkneearthroplastyconsecutivecaseseriesstudy |